Effects of Atomized Dexmedetomidine on Lung Function in Patients With Chronic Obstructive Pulmonary Disease

NCT06207331 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped no patient enrolled.

Conditions

Respiratory Function Tests
Chronic Obstructive Pulmonary Disease
Dexmedetomidine

Interventions

DRUG: Dexmedetomidine 0.5 μg/kg
DRUG: Dexmedetomidine 1 μg/kg
DRUG: Saline

Sponsor

The Second Affiliated Hospital of Chongqing Medical University